The Unique Challenges of Pharma Content
Most content challenges are ubiquitous, present in every vertical. Processes that don’t scale. Too much content to manage and yet the exact right content never seems to be at hand. Authors must copy and paste and (inevitably) tweak content, wasting time and increasing risk. The challenges of time, cost, and
Manage the Information, Not (Just) the Document
For centuries, humans have shared information through documents. We’ve used digital files, printed paper, illuminated manuscripts, parchment scrolls, and clay tablets. Regardless of form factor, a document has traditionally been created as a single monolithic entity, authored in the same format in which it was intended to be consumed.
COVID and Content: The Role of Content in Getting Vaccines to Market Quickly
The COVID-19 pandemic put tremendous pressure on drug-development organizations to accelerate product development far beyond anyone’s wildest roadmaps.
Accept My Intelligence: Why AI Should Ask, Not Assume
Recently, I was working through some challenges with a custom schema that supports the structured content model for one of my pharma customers. I needed to take an existing document and lay it out with both the old schema and the new schema and make sure all the proposed changes
What Is a Reuse Map?
A reuse map is a blueprint for planned content reuse. Planned content reuse means that you identify ahead of time exactly which pieces of content will be reused in a specific output.
Artificial Intelligence Is Just Complicated Math
Earlier this year, I took a course on artificial intelligence taught at the Executive Education division of the UC Berkeley Haas School of Management. The course was primarily focused on AI business strategies and applications.
To Chunk or Not to Chunk? 3 Questions to Help You Decide
A question came up recently in a conversation about structured authoring and a migration into a component content management system: “If we’re not going to reuse this content, and it is always entirely unique, do we still need to chunk it into components?”
MedTech: The Time is Now for Structured Content
I recently came across a great commentary in the August 2021 issue of “Pharma Technology Focus.” The article is titled, “MDR set to transform how MedTech firms approach content management,” written by Barbara Peraltor, Director of Life Science Solutions at Amplexor.
Solving the 6 Challenges of Medical Device Content
EU Medical Device Regulation (2017/745) and In Vitro Diagnostic Regulation (2017/746) went into effect in May 2021, after about a year’s delay due to COVID-19. Medical device manufacturers have known about the new regulations for years and have been working to meet these new, more stringent standards.
Is Structured Content Ready for Pharma?
I’ve had more than one conversation over the past several years about whether pharmaceutical companies were “ready” for structured content. After all, many of the benefits of structured content roll up into one key business need: scale. And scale — the ability to produce a lot of content quickly, accurately,
Buy this Book to learn exactly what it takes to deliver personalized experiences at scale.
our recent posts
Get exclusive access to Val’s thoughts and hand-picked content with our newsletter.
“*” indicates required fields
browse by topic
- Additional Resources (1)
- Artificial intelligence (25)
- Blogs (136)
- Books (1)
- Content Operations (97)
- Content strategy (19)
- Content Strategy & Personalization (53)
- eBooks (9)
- Global readiness (8)
- Knowledge management (6)
- Personalization (19)
- Pharmaceutical (34)
- Regulatory compliance (8)
- Videos (16)
- White papers (4)
- Workflow & Governance (17)
- Workplace practices (2)